Abstract
Microfluidic devices have been established as useful platforms for cell culture for a broad range of applications, but challenges associated with controlling gradients of oxygen and other soluble factors and hemodynamic shear forces in small, confined channels have emerged. For instance, simple microfluidic constructs comprising a single cell culture compartment in a dynamic flow condition must handle tradeoffs between sustaining oxygen delivery and limiting hemodynamic shear forces imparted to the cells. These tradeoffs present significant difficulties in the culture of mesenchymal stem cells (MSCs), where shear is known to regulate signaling, proliferation, and expression. Several approaches designed to shield cells in microfluidic devices from excessive shear while maintaining sufficient oxygen concentrations and transport have been reported. Here we present the relationship between oxygen transport and shear in a “membrane bilayer” microfluidic device, in which soluble factors are delivered to a cell population by means of flow through a proximate channel separated from the culture channel by a membrane. We present an analytical model that describes the characteristics of this device and its ability to independently modulate oxygen delivery and hemodynamic shear imparted to the cultured cells. This bilayer configuration provides a more uniform oxygen concentration profile that is possible in a single-channel system, and it enables independent tuning of oxygen transport and shear parameters to meet requirements for MSCs and other cells known to be sensitive to hemodynamic shear stresses.
INTRODUCTION
Microfluidic devices have emerged as powerful tools for controlling the cellular microenvironment1, 2, 3, 4 and for assembling tissuelike structures,5, 6 as well as enabling high-throughput analysis.7, 8, 9, 10 A notable advantage of microfluidic cell culture is the potential to control concentrations of nutrients, growth factors, and other soluble cellular regulatory molecules both spatially and temporally. Microfluidic culture systems are particularly suited to controlling concentration gradients of soluble factors by generating defined gradients and eliminating undesirable gradients.11, 12, 13, 14, 15
An enduring challenge in many in vitro culture formats including microfluidic cultures is the relatively poor solubility of oxygen in culture medium compared to its solubility in blood. This low solubility results in very rapid depletion of oxygen compared to other low molecular weight nutrients, and can result in gradients of oxygen along the flow path in microscale culture devices.16 Although gradients are in some cases desirable, when they are induced by cellular consumption, the magnitude of the gradients can be difficult to control.17, 18 Gradients can be reduced by increasing the flow rate of culture medium, but doing so increases the magnitude of shear stress experienced by cells exposed directly to flow, potentially exceeding physiological values. Shear stress is well known to govern the phenotype of endothelial cells,19, 20, 21, 22 and shear is emerging as an important regulator of behavior in other cell types. For example, shear stresses have been shown to regulate activation of signaling pathways, gene expression, proliferation, and osteogenesis in mesenchymal stem cells (MSCs).23, 24, 7, 25, 26 Several approaches have been developed to uncouple oxygen transport and fluid shear stress on cells cultured in microfluidic reactors, including culturing cells in biologically inspired microchannels which shield them from fluid flow,13 in bilayer constructs,27 and in recessed grooves.12
In addition to oxygen, cells consume and produce numerous growth factors that regulate survival, growth, differentiation, and migration. Convective flow enhances the molecular transport of such factors to a greater degree than oxygen due to their larger size and lower diffusion coefficients.28 While it is possible to control the concentrations of exogenous factors such as insulin, it is difficult to control the gradients of autocrine factors in the presence of significant flow.29, 30, 31
A two-compartment microfluidic device (Fig. 1), in which the cell culture region is separated from a high-flow channel by a semipermeable membrane, offers the possibility of uncoupling oxygen and molecular transport from the shear stress imparted to the cells. Such a design is similar to macroscale hollow fiber reactor platforms used for industrial protein production.32 The flow rate in the upper channel (Fig. 1) is set at a relatively high rate, determined by minimizing the concentration drop of oxygen or other components along the length of the flow channel. Modulation of the transmembrane pressure and membrane permeability enables precise control of local concentrations in the culture chamber. Devices incorporating semipermeable membranes with low hydraulic conductivity and tailored molecular weight cutoffs are expected to minimize effects of convective transport between the chambers, enabling fluxes of nutrients and macromolecules to the cell layer to be governed by the membrane permeability coefficients. High molecular weight autocrine factors can be retained in the cell compartment without significant restriction on oxygen transport by restricting the flux through the membrane by the appropriate choice of molecular weight cutoff.
These design considerations derive from a growing interest in illuminating the role of oxygen and other soluble factors in regulating the survival, growth, and differentiation of stem cells.33, 34, 35, 36, 37, 38, 39 Very low oxygen concentrations are often reported to foster greater retention of desirable stem cell behaviors, for instance, proliferation. However, culturing cells at low oxygen concentrations exacerbates the rapid depletion from flowing culture medium. We therefore analyze the design of two-compartment membrane devices to determine operating parameters that will enable a uniform, low oxygen concentration to be achieved at the cell layer shown in Fig. 1, and evaluate the consequences for molecular transport of other species important in regulating cell behavior.
ANALYTICAL MODEL OF FLUID SHEAR AND MOLECULAR TRANSPORT IN A TWO-COMPARTMENT BILAYER DEVICE
A cross-section depicting the flow geometry under consideration is illustrated in Fig. 2, which also defines the parameters governing the flow and transport. The general case allows for flow in both channels (as shown in the figure), but in practice, it may be favorable to eliminate flow in the lower channel for some culture scenarios. For the limiting case of negligible convective flow across the semipermeable membrane separating the flow channels, and for high aspect ratio flow channels (L⪢h), steady state velocity profiles in either channel can be described by fully developed Poiseuille flow, as shown in Fig. 2. Convective transport across the membrane will be low for membranes with small pores and low porosity, such as PDMS or track-etched polymer membranes.27 In the limit of negligible membrane permeability to fluid, oncotic effects will vanish. In channels with aspect ratios w∕h∼10, a common experimental situation,40, 41, 42, 43 the two-dimensional assumption is valid across middle 85% of the channel to an error of 1; for w∕h=4, the approximation still holds for the central 62% of the channel (Supplementary Information, Fig. 2).44
A comparison of the relative diffusive and convective transport time scales in the x direction along the channel, captured by the Peclet number Pe=u0L∕D, indicates that molecular transport of oxygen (or other solutes) in the x direction (along the length of the channel) is dominated by convection. For typical values of L (0.1–1 cm), u0 (1×10−2 cm∕s), and D (1–30×10−6 cm2∕s), values of Pe are between 16 and 1×106. In this configuration, convection dominates where Pe>10.
With these considerations, the equations governing diffusion and convection of solute in the two different regions are identical in form and are simplified to the following:
(1) |
where the solute concentrations in the upper and lower channels are CII and CI, respectively, and ui is the velocity of the fluid in the horizontal (x) direction. The Poiseuille velocity profile in terms of the device geometric parameters is given by
(2) |
with the shear imparted on the walls by this flow field given by τi=μi[∂ui(y)∕∂y]y=0,hi. The corresponding flow rates are , where w is the width of the channel.
Fluid enters each channel (x=0) at a defined concentration C0, and there is no flux of solute across the upper wall of the top chamber. This latter condition does not strictly hold true for devices made from PDMS due to the high oxygen solubility in PDMS;16 it is a reasonable assumption for alternate less-permeable materials now being employed for devices.28 Cells consuming oxygen along the lower wall in the lower chamber create a diffusive flux of oxygen across the central membrane separating the two channels. Defining Dmembrane as the effective diffusion coefficient of the solute in the membrane, and t the thickness of the membrane, the boundary conditions in the upper chamber may be summarized as
(3) |
In the lower chamber, we take the inlet concentration of solute is zero. Solute diffuses into the lower chamber from the upper chamber across the membrane. The rate of diffusive flux at the upper boundary (membrane) is balanced by the flux at the lower boundary, where cells consume the solute. Solute consumption generally follows Michaelis–Menten kinetics, allowing the boundary conditions for the lower channel to be summarized as
(4) |
where Vmax is the maximum rate of consumption of solute, KM is the Michaelis–Menten constant, and ρcells is the area density of the cells. Michaelis–Menten parameters have been reported for oxygen consumption by a wide variety of cell types including mesenchymal stem cells.33, 45, 35, 36 A particular application focus for the device design described herein is culture of MSCs under very low oxygen tensions, such as those that might obtain during embryonic development37 or in the marrow or a wound environment. In response to a low oxygen tension, MSCs upregulate hypoxia-induced factors that then control cell behaviors such as proliferation and differentiation (e.g., into osteoblasts or chondrocytes).38, 39 For oxygen consumption by mammalian cells, a wide range of values have been reported for KM, the critical parameter that governs the transition between zero-order (at high solute concentrations) and first-order (low solute concentrations) kinetic regimes, but values in the 5%–30% of air saturation are typical.33, 35 Thus, for culture at target oxygen tensions in the range of <20% of air saturation, it is reasonable to presume the first-order limit of the Michaelis–Menten kinetic expression applies. This allows the boundary condition at the lower boundary of the lower channel to be simplified to
Typical parameter values for microfluidic cell culture, where oxygen is the solute of interest, are summarized in Table 1. Table 2 summarizes three combinations of parameter values of interest, ranging from low (Case 1) to high (Case 3) uptake rates (given by the ratio Vmax∕KM), as well as varying cell seeding densities, ranging from sparse (Case 1) to confluent (Case 3).
Table 1.
Parameter | Value | Note |
---|---|---|
DII,DI | 3×10−5 cm2∕s | Diffusion coefficient for oxygen in water |
Dmembrane | 1×10−5 cm2∕s | Diffusion coefficient for oxygen in polymeric membranea |
t | 10 μm | Thickness of membrane |
μ | 1×10−2 dyne s∕cm2 | Viscosity of water |
hI,hII | 50 μm | Height of channelb |
w | 200 μm | Width of channelb |
L | 1.5 cm | Length of channelb |
KM | 1×10−7 mol∕cm3 | Michaelis–Menten parameter for oxygenc |
Csat | 2.15×10−7 mol∕cm3 | Oxygen concentration at saturationd |
C0 | 2.15×10−9 mol∕cm3 | 0.01×Csat, 1% saturationd |
τ | 0.3 dyne∕cm2 | Shear, determined by initiation of osteogenic differentiation in MSCse |
Table 2.
The range of suitable flow rates in the cell compartment, should flow be desired, can be determined by considering threshold values that have been reported to affect MSC cell phenotypes. In this regard, proliferation and osteogenic differentation are affected by shear in a range between 0.3 and 2.7 dyne∕cm2.25, 46 We therefore take as an upper threshold value for the shear in the lower compartment, should flow be included during operation, of τ=0.3 dyne∕cm2. This constraint sets the maximum allowable volumetric flow rate in the lower channel at a level QI=2.5 nL∕s. Flow rates of this order have been used to culture stem cells in work that has successfully sustained cells over a sustained period of time and removed metabolic waste products.25, 46 There are no corresponding maximum limits on flow in the upper channel, QII, because it can be modulated without affecting the shear imparted to the MSCs due to the shielding effect of the membrane. A channel height of 50 μm and a channel length of 1.5 cm are selected based on experimental values for comparable devices.41, 42
RESULTS
In Fig. 3, model results for oxygen concentration at the cell surface for the bilayer and single channel case are shown. The least stringent set of culture conditions for maintaining oxygen concentrations invariant down the length of the devices involves sparse cells respiring at the lower end of the reported ranges of consumption rates (Case 1, Table 2). For flow rates QI=2.5 nL∕s (governed by maximum allowable shear on the cell layer) with QII=10 nL∕s in the upper channel (solid black line), the oxygen concentration profile is almost invariant along the length of the cell compartment except for a small zone of depletion in the initial region, due to the assumption of zero concentration in the inlet. If, instead of using a bilayer membrane device, where the membrane protects cells from high shear flow required to deliver oxygen by diffusion, cells were cultured in a single channel configuration with a low flow rate (given by Q=2.5 nL∕s), to protect them from shear (i.e., τ=0.3 dyne∕cm2), the oxygen concentration falls rapidly along the length of the channel (dashed black line). The concentration profile for increasing flow to 25 nL∕s (comparable to the flow in the upper channel in the bilayer device) in this single channel comparative situation diminishes this drop, but at the cost of an unacceptable increase in shear stress (to 3 dyne∕cm2).
The concentration profiles themselves can be visualized using color maps over the domain of interest. We see in Fig. 4a that, with QI=2.5 nL∕s and QII=25 nL∕s, the concentration field in the cell compartment for the bilayer case is nearly uniform. For the single channel configuration operating at a flow rate of Q=2.5 nL∕s [Fig. 4b], there exists considerable nonuniformity in the concentration profile along the length of the channel.
Increasing the cell density and respiration parameters (corresponding to Cases 2 and 3) for these same flow rates (2.5 nL∕s the lower chamber and 25 nL∕s in the upper chamber) results in development of oxygen concentration profiles down the length of the device for Case 3 but a near-constant linear profile is maintained for Case 2 [Fig. 5a]. The concentration profile can be flattened for Case 3 by increasing the volumetric flow rate in the upper compartment by a factor of 5, so that QII=125 nL∕s [Fig. 5b]. This increase in flow rate has no consequence on the shear stress experienced by the cells, as they are shielded by the semipermeable membrane.
In Fig. 6, we see the effect of simply increasing the concentration of solute introduced into the flow channel. As expected, the concentration increases along the length of the channel.
Discussion
The results presented in Figs. 3456 describe the range of operating parameters that enable a bilayer membrane microfluidic device to provide uniform, tailored levels of oxygen to various densities of cultured MSCs, while shielding cells from shear stresses induced by the volumetric flow rates necessary to deliver oxygen. In the bilayer case, however, it is possible to achieve controlled levels of oxygen delivery without an unacceptable increase in the shear stress to which the cells are exposed. Significantly, we see in Figs. 3456 that the concentration and delivery profiles are, except for the entry zone, nearly uniform.
In the analysis presented in Figs. 3456, an extreme boundary condition of zero inlet oxygen was employed, although in practice, the inlet oxygen concentration could be tailored to whatever value is desired. This use of this extreme boundary condition, however, provides an estimate of the length scale over which effects of the lower inlet oxygen concentration persist before diffusion from the upper chamber reaches a fully developed state. Intuitively, it is anticipated that the entry zone effects for the extreme boundary condition (zero inlet oxygen in the lower flow channel) will be diminished for lower flow rates in the lower channel. For example, if QI is decreased from 10 nL∕s to 2.5 nL∕s with the flow channel flow rate QII decreased from 100 nL∕s to 43.75 nL∕s, the entry zone depletion region is reduced by a factor of 4 (Fig. 7, blue line and dashed black line, respectively).
Implications for device design
One aspect that has been assumed in this analysis is the fully developed nature of the fluid flow. In practice, it is often useful to ensure that the fluid flow within the operational portions of the device is both laminar and fully developed. With fully developed flow, the velocity field is assumed to be the same along the operating length of the device. Other device configurations designed to shield cells from stress, such as those featuring grooves13 or complex channel geometries,12 may introduce mixing and other effects that could interfere with the dynamic measurement of quantities of interest, such as oxygen concentration, and which would introduce complex flow and concentration fields under the high flow conditions required to maintain a relatively constant concentration field along the length of the device. In order to characterize the entry length for the fluid, we may refer to one of the several correlations that describe the entry length for a fluid, e.g.,51
(5) |
where Dh is the hydraulic diameter of the channel, given by 2hw∕(h+w), and ReL is the Reynolds number for the flow, given by ρfluidu0L∕μ. For the values given in Table 1, we have ReL=4.2, Dh=80 μm, and Lentrance=60 μm, while the delivery profile (i.e., the depletion zone) may be tuned as above to extend beyond this range.
CONCLUSION
We have constructed an analytical model that demonstrates the transport profile in a membrane bilayer cell culture device that enables tunable modulation of transport and fluid shear. We have shown that the bilayer configuration allows us to maintain nearly uniform concentration profiles along a length of channel while subjecting cultured cells to minimal shear. This represents an improvement over conventional microfluidic cell culture devices comprising a single channel configuration, in which uniformity in solute concentration along the length of the channel is achieved only by increasing flow rate, which increases shear imparted to cells. We have shown the potential for tuning the oxygen delivery profile within a model cell culture system. The model presented here may be used as a baseline for device design and parameter selection in the construction of a microfluidic device for tissue culturing, bioassay, and drug delivery systems. Furthermore, the basic physics of this model may be extended to consider more complex systems involving the interaction of several soluble factors in devices comprised of varying cell populations and types.
ACKNOWLEDGMENTS
The project described was supported by Award No. R01EB010246 from the National Institute of Biomedical Imaging & Bioengineering. The content is solely the responsibility of the authors and does not necessary represent the official views of the National Institute of Biomedical Imaging & Bioengineering or the National Institutes of Health.
APPENDIX: SOLUTION TO THE TRANSPORT EQUATION FOR A MEMBRANE BILAYER
Solution
This section describes the method used to arrive at the solution. In order to make the solutions more broadly applicable, the equations are cast in nondimensional form. A characteristic fluid velocity is defined for each region, depending on the given pressure gradient and height. Additionally, the characteristic concentration is C0, corresponding to the inlet concentration which is being introduced at the left of the upper region. Scale x and y against the height of the lower channel hI, and let ΩII and ΩI denote the flow channel and cell compartment, respectively. Then the dimensionless transport equation is, for the upper channel,
(A1) |
and for the lower channel,
(A2) |
where β≡hII∕hI, and PeII≡u0,IIhI∕DII and PeI≡u0,IhI∕DI are the Peclet numbers for each channel. u0,II is equal to and u0,I equal to In terms of flow rates QI and QII in ΩI and ΩII, respectively, we may write the Peclet numbers,
The shear along the walls τi is given by
A separation of variables methodology may be used to derive the general solutions for Eqs. A1, A2. Writing Ci(x,y)=ξi(x)ηi(y) (i=I,II) and separating, we have in ΩI,
and in ΩII,
where and are some constants to be determined. The left sides may be integrated to give
where Ai is a constant of integration. The equations to solve for ηi(y) are given by
These may be solved for by a method of power series, where ηi is expanded in powers of y as ∑nanyn and ηII in powers of y∕β as ∑nan(y∕β)n. If we do this, we may write the general solutions to the separated equations as
and
where the coefficients , , , and are given in Appendix0, subsection 03 and a1,I and a1,II are to be determined.
Application of boundary conditions to solution
The boundary conditions may be nondimensionalized as well, so that we now have in the upper channel
(A3) |
where Sh is the Sherwood number, and in the lower channel,
(A4) |
where Da is the Damkohler number.
For ΩII, the no-flux boundary condition on the top surface gives
In ΩI, the lower boundary condition gives a1,I=Da. If we apply the membrane boundary conditions, we have
so that
and
so that
Setting the two expressions equal gives
(A5) |
Since the quantity
is equal to constants, the additional constraint
(A6) |
must be satisfied. Solving Eqs. A5, A6 will give a number of possible values for λII and subsequently λI. The linear combinations
(A7) |
(A8) |
form the general solution, where each CI,i and CII,i is a set of solutions characterized by the linked characteristic values and , where we define Γ≡PeII∕PeI.
Since we have , it may be shown that
(A9) |
(A10) |
Equations A9, A10 allow us to complete our description of the solution to Eqs. A1, A2. Nondimensionally, the consumption may be given by
Expansion coefficients
The coefficients for the expansions given for the solution are given in the tables below. We must divide by β2 for the flow compartment.
a1=0 | |||
---|---|---|---|
Coefficient | Value(∕β2) | ||
1 | |||
0 | |||
0 | |||
−λ2∕6 | |||
λ2∕12 | |||
0 | |||
λ4∕180 | |||
−λ4∕168 | |||
λ4∕672 | |||
−λ6∕12960 | |||
16λ6∕125131 |
a0=0 | |||
---|---|---|---|
Coefficient | Value(∕β2) | ||
0 | |||
1 | |||
0 | |||
0 | |||
−λ2∕12 | |||
λ2∕20 | |||
0 | |||
λ4∕504 | |||
−λ4∕420 | |||
λ4∕1440 | |||
−λ6∕45360 |
Solution
The final expressions for the concentrations in the flow chamber and cell compartment read, respectively,
(A11) |
(A12) |
where u0,II is equal to and u0,I equal to , and and are given by the solutions to Eqs. A5, A6. Finally, consumption is given by
References
- Borenstein J. T., in Comprehensive Microsystems, edited by Gianchandani Y. B., Tabata O., and Zappe H. (Elsevier, Amsterdam, 2008), Vol. 2, pp. 541–584. 10.1016/B978-044452190-3.00040-9 [DOI] [Google Scholar]
- Gupta K., Kim D. H., Ellison D., Smith C., Kundu A., Tuan J., Suh K. Y., and Levchenko A., Lab Chip 10, 2019 (2010). 10.1039/c004689b [DOI] [PubMed] [Google Scholar]
- Beebe D. J., Mensing G. A., and Walker G. M., Annu. Rev. Biomed. Eng. 4, 261 (2002). 10.1146/annurev.bioeng.4.112601.125916 [DOI] [PubMed] [Google Scholar]
- Kim D. H., Wong P. K., Park J., Levchenko A., and Sun Y., Annu. Rev. Biomed. Eng. 11, 203 (2009). 10.1146/annurev-bioeng-061008-124915 [DOI] [PubMed] [Google Scholar]
- Khademhosseini A. Langer R. Borenstein J., and Vacanti J. P., Proc. Natl. Acad. Sci. U.S.A. 103, 2480 (2006). 10.1073/pnas.0507681102 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bettinger C. J., Weinberg E. J., Kulig K. M., Vacanti J. P., Wang Y., Borenstein J. T., and Langer R., Adv. Mater. (Weinheim, Ger.) 18, 165 (2006). 10.1002/adma.200500438 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gómez-Sjöberg R., Leyrat A. A., Pirone D. M., Chen C. S., and Quake S. R., Anal. Chem. 79, 8557 (2007). 10.1021/ac071311w [DOI] [PubMed] [Google Scholar]
- Sia S. K. and Whitesides G. M., Electrophoresis 24, 3563 (2003). 10.1002/elps.200305584 [DOI] [PubMed] [Google Scholar]
- Desbordes S. C., Placantonakis D. G., Ciro A., Socci N. D., Lee G., Djaballah H., and Studer L., Stem Cells 2, 602 (2008). 10.1016/j.stem.2008.05.010 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Melin J., Lee A., Foygel K., Leong D. E., Quake S. R., and Yao M. W., Dev. Dyn. 238, 950 (2009). 10.1002/dvdy.21918 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Amadi O. C., Steinhauser M. L., Nishi Y., Chung S., Kamm R. D., McMahon A. P., and, Lee R. T., Biomed Microdevices 12, 1027 (2010). 10.1007/s10544-010-9457-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sandstrom C. E., Bender J. G., Miller W. M., and Papoutsakis E. T., Biotechnol. Bioeng. 50, 493 (1996). [DOI] [PubMed] [Google Scholar]
- Lee P. J., Hung P. J., and Lee L. P., Biotechnol. Bioeng. 97, 1340 (2007). 10.1002/bit.21360 [DOI] [PubMed] [Google Scholar]
- Chung B. G., Flanagan L. A., Rhee S. W., Schwartz P. H., Lee A. P., Monuki E. S., and Jeon N. L., Lab Chip 5, 401 (2005). 10.1039/b417651k [DOI] [PubMed] [Google Scholar]
- Sun K., Wang Z., and Jiang X., Lab Chip 8, 1536 (2008). 10.1039/b806140h [DOI] [PubMed] [Google Scholar]
- Mehta G., Mehta K., Sud D., Song J. W., Bersano-Begey T., Futai N., Heo Y. S., Mycek M. -A., Linderman J. J., and Takayama S., Biomed. Microdevices 9, 123 (2007). 10.1007/s10544-006-9005-7 [DOI] [PubMed] [Google Scholar]
- Lo J. F., Sinkala E., and Eddington D. T., Lab Chip 10, 2394 (2010). 10.1039/c004660d [DOI] [PMC free article] [PubMed] [Google Scholar]
- Zhu X., Chu L. Y., Chueh B. H., Shen M., Hazarika B., Phadkea N., and Takayama S., Analyst (Cambridge, U.K.) 129, 1026 (2004). 10.1039/b407623k [DOI] [PubMed] [Google Scholar]
- Wang H., Riha G. M., Yan S., Li M., Chai H., Yang H., Yao Q., and Chen C., Arterioscler. Thromb. Vasc. Biol. 25, 1817 (2005). 10.1161/01.ATV.0000175840.90510.a8 [DOI] [PubMed] [Google Scholar]
- Nagel T., Resnick N., C. F.Dewey, Jr., and M. A.Gimbrone, Jr., Arterioscler. Thromb. Vasc. Biol. 19, 1825 (1999). [DOI] [PubMed] [Google Scholar]
- García-Cardeña G., Comander J., Anderson K. R., Blackman B. R., and M. A.Gimbrone, Jr., Proc. Natl. Acad. Sci. U.S.A. 98, 4478 (2001). 10.1073/pnas.071052598 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tzima E., Del Pozo M. A., Shattil S. J., Chien S., and Schwartz M. A., EMBO J. 20, 4639 (2001). 10.1093/emboj/20.17.4639 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Scaglione S., Wendt D., Miggino S., Papadimitropoulos A., Fato M., Quarto R., and Martin I., J. Biomed. Mater. Res. 87A, 411 (2007). [DOI] [PubMed] [Google Scholar]
- Zhao F., Chella R., and Ma T., Biotechnol. Bioeng. 96, 584 (2007). 10.1002/bit.21184 [DOI] [PubMed] [Google Scholar]
- Glossop J. R. and Cartmell S. H., Gene Expr. Patterns 9, 381 (2009). 10.1016/j.gep.2009.01.001 [DOI] [PubMed] [Google Scholar]
- Riddle R. C., Taylor A. F., Genetos D. C., and Donahue H. J., Am. J. Physiol.: Cell Physiol. 290, C776 (2005). 10.1152/ajpcell.00082.2005 [DOI] [PubMed] [Google Scholar]
- Carraro A., Hsu W., Kulig K. M., Cheung W. S., Miller M. L., Weinberg E. J., Swart E. F., Kaazempur-Mofrad M., Borenstein J. T., Vacanti J. P., and Neville C., Biomed. Microdevices 10, 795 (2008). 10.1007/s10544-008-9194-3 [DOI] [PubMed] [Google Scholar]
- Griffith L. G. and Swartz M. A., Nat. Rev. Mol. Cell Biol. 7, 211 (2006). 10.1038/nrm1858 [DOI] [PubMed] [Google Scholar]
- Semino C. E., Kamm R. D., and Lauffenburger D. A., Exp. Cell Res. 312, 289 (2006). [DOI] [PubMed] [Google Scholar]
- Swartz M. A. and Fleury M. E., Annu. Rev. Biomed. Eng. 9, 229 (2007). 10.1146/annurev.bioeng.9.060906.151850 [DOI] [PubMed] [Google Scholar]
- Bonvin C., Overney J., Shieh A. C., Dixon J. B., and Swartz M. A., Biotechnol. Bioeng. 105, 982 (2010). [DOI] [PubMed] [Google Scholar]
- Cima L. G., Blanch H. W., and Wilke C. R., Bioprocess Eng. 5, 19 (1990). 10.1007/BF00369643 [DOI] [Google Scholar]
- Zhao F., Pathi P., Grayson W., Xing Q., Locke B. R., and Ma T., Biotechnol. Prog. 21, 1269 (2005). 10.1021/bp0500664 [DOI] [PubMed] [Google Scholar]
- Kallos M. S. and Behie L. A., Biotechnol. Bioeng. 63, 473 (1999). [DOI] [PubMed] [Google Scholar]
- Chin V. I., Taupin P., Sanga S., Scheel J., Gage F. H., and Bhatia S. N., Biotechnol. Bioeng. 88, 399 (2004). 10.1002/bit.20254 [DOI] [PubMed] [Google Scholar]
- Simon M. C. and Keith B., Nat. Rev. Mol. Cell Biol. 9, 285 (2008). 10.1038/nrm2354 [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mayer H., Bertram H., Lindenmaier W., Korff T., Weber H., and Weich H., J. Cell. Biochem. 95, 827 (2005). 10.1002/jcb.20462 [DOI] [PubMed] [Google Scholar]
- Fehrer C., Brunauer R., Laschober G., Unterluggauer H., Reitinger S., Kloss F., Gülly C., Gaßner R., and Lepperdinger G., Aging Cell 6, 745 (2007). 10.1111/j.1474-9726.2007.00336.x [DOI] [PubMed] [Google Scholar]
- Shiku H., Saito T., Wu C. C., Yasukawa T., Yokoo M., Abe H., Matsue T., and Yamada H., Chem. Lett. 35, 234 (2006). 10.1246/cl.2006.234 [DOI] [Google Scholar]
- Lu H., Koo L. Y., Wang W. M., Lauffenburger D. A., Griffith L. G., and Jensen K. F., Anal. Chem. 76, 5257 (2004). 10.1021/ac049837t [DOI] [PubMed] [Google Scholar]
- Hoganson D. M., Finkelstein E. B., Owens G. E., Hsiao J. C., Eng K. Y., Kim E. S., Borenstein J. T., Pomerantseva I., Neville C. M., Turk J. R., and Vacanti J. P., TERMIS-NA Meeting, San Diego, CA, 2008.
- Duncanson S., Keegan M. E., Finkelstein E. B., Owens G. E., Soong R., Hsiao J., Eng K. Y., Pomerantseva I., Neville C. M., Hoganson D. M., Vacanti J. P., Turk J. R., and Borenstein J. T., TERMIS-NA Meeting, San Diego, CA, 2008.
- Cimetta E., Figallo E., Cannizzaro C., Elvassore N., and Vunjak-Novakovic G., Methods 47, 81 (2009). 10.1016/j.ymeth.2008.10.015 [DOI] [PMC free article] [PubMed] [Google Scholar]
- See supplementary material at http://dx.doi.org/10.1063/1.3576925 for a derivation of the flow field in a three-dimensional rectangular channel.
- Fournier R. L., Basic Transport Phenomena in Biomedical Engineering (Taylor & Francis, Bristol, 1999), pp. 45, 96–and 121.96, and 121. [Google Scholar]
- Kreke M. R. and Goldstein A. S., Tissue Eng. 10, 780 (2004). 10.1089/1076327041348455 [DOI] [PubMed] [Google Scholar]
- Matsumura T., Kauffman F. C., Meren H., and Thurman R. G., Am. J. Physiol. 250, G800 (1986). [DOI] [PubMed] [Google Scholar]
- Tsai C. C., Chen Y. J., Yew T. L., Chen L. L., Wang J. Y., Chiu C. H., and Hung S. C., Blood 117, 459 (2011). 10.1182/blood-2010-05-287508 [DOI] [PubMed] [Google Scholar]
- Powers M. J., Rodriguez R. E., and Griffith L. G., Biotechnol. Bioeng. 53, 415 (1997). [DOI] [PubMed] [Google Scholar]
- Majors A. K., Boehm C. A., Nitto H., Midura R. J., and Muschler G. F., J. Orthop. Res. 15, 546 (1997). 10.1002/jor.1100150410 [DOI] [PubMed] [Google Scholar]
- Abgrall P. and Nguyen N. T., Nanofluidics (Artech House, Boston, 2009), p. 14. [Google Scholar]